Suppr超能文献

结直肠内镜黏膜切除术后的内镜下瘢痕评估:何时需要活检(内镜瘢痕评估项目(ESCAPE)试验)。

Endoscopic scar assessment after colorectal endoscopic mucosal resection scars: when is biopsy necessary (EMR Scar Assessment Project for Endoscope (ESCAPE) trial).

机构信息

Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida, USA.

Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, The Netherlands.

出版信息

Gut. 2019 Sep;68(9):1633-1641. doi: 10.1136/gutjnl-2018-316574. Epub 2019 Jan 11.

Abstract

OBJECTIVE

It is unclear whether endoscopic assessment of scars after colorectal endoscopic mucosal resection (EMR) has to include biopsies, even if endoscopy is negative. Vice versa, endoscopic diagnosis of recurrent adenoma may not require biopsy before endoscopic reinterventions. We prospectively analysed various endoscopic modalities in the diagnosis of recurrence following EMR.

DESIGN

We conducted a prospective study of patients undergoing colonoscopy after EMR of large (≥20 mm) colorectal neoplasia. Endoscopists predicted recurrence and confidence level with four imaging modes: high-definition white light (WL) and narrow-band imaging (NBI) with and without near focus (NF). Separately, 26 experienced endoscopists assessed offline images.

RESULTS

Two hundred and thirty patients with 255 EMR scars were included. The prevalence of recurrent adenoma was 24%. Diagnostic values were high for all modes (negative predictive value (NPV) ≥97%, positive predictive value (PPV) ≥81%, sensitivity ≥90%, specificity ≥93% and accuracy ≥93%). In high-confidence cases, NBI with NF had NPV of 100% (95% CI 98% to 100%) and sensitivity of 100% (95% CI 93% to 100%). Use of clips at initial EMR increased diagnostic inaccuracy (adjusted OR=1.68(95% CI 1.01 to 2.75)). In offline assessment, specificity was high for all imaging modes (mean: ≥93% (range: 55%-100%)), while sensitivity was significantly higher for NBI-NF (82%(72%-93%)%)) compared with WL (69%(38%-86%); p<0.001), WL-NF (68%(55%-83%); p<0.001) and NBI (71%(59%-90%); p<0.001).

CONCLUSION

Our study demonstrates very high sensitivity and accuracy for all four imaging modalities, especially NBI with NF, for diagnosis of recurrent neoplasia after EMR. Our data strongly suggest that in cases of high confidence negative optical diagnosis based on NBI-NF, no biopsy is needed to confirm absence of recurrence during colorectal EMR follow-up. A high confidence positive optical diagnosis can lead to immediate resection of any suspicious area. In all cases of low confidence, biopsy is still required.

TRIAL REGISTRATION NUMBER

NCT02668198.

摘要

目的

即使内镜检查结果为阴性,结直肠内镜黏膜切除术(EMR)后评估疤痕是否需要进行活检也仍不明确。反之,内镜诊断复发性腺瘤时,在进行内镜再次干预之前可能不需要进行活检。我们前瞻性地分析了 EMR 后诊断复发时各种内镜检查方法的应用。

设计

我们对接受 EMR 治疗的大型(≥20mm)结直肠肿瘤患者进行了一项前瞻性研究。内镜医生使用四种成像模式(高清白光(WL)和窄带成像(NBI),以及有无近焦(NF))预测复发和置信水平。另外,26 名经验丰富的内镜医生单独对离线图像进行了评估。

结果

共纳入 230 例 255 处 EMR 疤痕患者。复发性腺瘤的患病率为 24%。所有模式的诊断价值均较高(阴性预测值(NPV)≥97%,阳性预测值(PPV)≥81%,敏感性≥90%,特异性≥93%,准确性≥93%)。在高置信度的情况下,NBI-NF 的 NPV 为 100%(95%CI 98%至 100%),敏感性为 100%(95%CI 93%至 100%)。初始 EMR 时使用夹增加了诊断的不准确性(调整后的 OR=1.68(95%CI 1.01 至 2.75))。在离线评估中,所有成像模式的特异性均较高(平均:≥93%(范围:55%至 100%)),而 NBI-NF 的敏感性明显高于 WL(69%(38%至 86%))、WL-NF(68%(55%至 83%))和 NBI(71%(59%至 90%))(均 p<0.001)。

结论

我们的研究表明,在 EMR 后诊断复发性肿瘤时,四种成像模式均具有非常高的敏感性和准确性,尤其是 NBI-NF。我们的数据强烈表明,在基于 NBI-NF 的光学诊断高度可信且为阴性的情况下,在结直肠 EMR 随访中无需进行活检即可确认无复发。光学诊断高度可信且为阳性可立即切除任何可疑区域。在所有低可信度的情况下,仍需要进行活检。

试验注册号

NCT02668198。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验